1369595-23-2

Upstream product

• 1369594-47-7 C₁₄H₉BrClNO 
• 1369594-46-6 C₁₄H₁₂BrClN₂O 
• 30186-18-6 4'-bromo-2'-hydroxyacetophenone 

Downstream Products

• 1369595-24-3 C₂₂H₁₄BrCl₂NO₂ 
• 1369595-25-4 C₃₄H₃₂Cl₂N₄O₄ 

Relevant academic research and scientific papers

HETEROCYCLE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A', R2 R3 and R5 are as defined herein. The present invention also relates to compositions comprising at least one Heterocycle-Substituted Tetracyclic Compound, and methods of using the Heterocycle-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient.

TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION

Tetracyclic indole derivatives of formula (I), pharmaceutically acceptable salts and the pharmaceutical compositions thereof are provided, wherein A, A', G, R1, R15, U, V, V, W, W, X, X', Y, Y' are as defined in the invention. Use of these derivatives for treating hepatitis C virus (HCV) infection is also provided.